We are live on ! Find out more
CYTO

Altamira Therapeutics Ltd
CYTO

Delisted

CYTO was delisted on the 19th of December, 2024.

Back to rankings

6 hedge funds and large institutions have $27.3M invested in Altamira Therapeutics Ltd in 2014 Q4 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 6 → 6 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

31% less capital invested

Capital invested by funds: $39.4M → $27.3M (-$12.1M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
6
Holders Change
–
Holders Change %
0%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
2
Increased
–
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CPCM
Clifton Park Capital Management
Delaware
+$7.41M
2
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$353K

Top Sellers

Rank Fund Capital Flow
1
TAM
Tiverton Asset Management
Delaware
-$9.62M
2
SFM
Sphera Funds Management
Israel
-$1.11M
3
CCP
Clough Capital Partners
Massachusetts
-$353K
4
Credit Agricole
Credit Agricole
France
-$82K
5
CSS
Cubist Systematic Strategies
Connecticut
-$60K
Name Holding Trade Value Shares
Change 		Change in
Stake
ABI
1
Adamant Biomedical Investments
Switzerland
$8.46M – – –
Fidelity Investments
2
Fidelity Investments
Massachusetts
$6.5M – – –
CPCM
3
Clifton Park Capital Management
Delaware
$6.5M +$7.41M +21 New
RCM
4
RA Capital Management
Massachusetts
$3.67M – – –
CCP
5
Clough Capital Partners
Massachusetts
$1.67M -$353K -1 -17%
Alyeska Investment Group
6
Alyeska Investment Group
Illinois
$234K +$353K +1 New
Goldman Sachs
7
Goldman Sachs
New York
$67K – – –
SIM
8
Spark Investment Management
New York
$67K – – –
Royal Bank of Canada
9
Royal Bank of Canada
Ontario, Canada
$47K – – –
Deutsche Bank
10
Deutsche Bank
Germany
$43K – – –
TRCT
11
Tower Research Capital (TRC)
New York
$9K – – –
TAM
12
Tiverton Asset Management
Delaware
– -$9.62M -21 Closed
SFM
13
Sphera Funds Management
Israel
– -$1.11M -2 Closed
Credit Agricole
14
Credit Agricole
France
– -$82K – –
CSS
15
Cubist Systematic Strategies
Connecticut
– -$60K – –
Morgan Stanley
16
Morgan Stanley
New York
– -$50K – –

CYTO Hedge Fund Activity: Q4 2014 in Review

6 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Altamira Therapeutics Ltd (CYTO) for Q4 2014, worth a combined $27.3M — down 31% from $39.4M a quarter earlier.

Fund positioning in CYTO was balanced in Q4 2014: 2 funds opened new positions, 2 closed out, 0 added to existing stakes and 1 trimmed.

The largest buyer was Clifton Park Capital Management, opening a new position worth an estimated $7.41M. The largest seller was Tiverton Asset Management, exiting entirely with an estimated $9.62M sold.

  • 6 institutional investors held Altamira Therapeutics Ltd (CYTO) as of Q4 2014, unchanged from Q3 2014.
  • Funds reported $27.3M of Altamira Therapeutics Ltd stock for Q4 2014, down 31% quarter-over-quarter.
  • 2 funds opened new Altamira Therapeutics Ltd positions in Q4 2014 and 2 closed out, a net change of 0 holders.
  • The largest Altamira Therapeutics Ltd buyer in Q4 2014 was Clifton Park Capital Management, an estimated $7.41M added.
  • The largest Altamira Therapeutics Ltd seller in Q4 2014 was Tiverton Asset Management, an estimated $9.62M sold.

Based on aggregated 13F filings for Q4 2014.